Jade Biosciences, Inc.

NASDAQ:JBIO

Biotechnology

Healthcare
$15.49 -1.25%

-$0.21 today

Market cap
$1.07B
Beta
1.45
P/E (TTM)
-7.4
EPS (TTM)
-$2.24
52W Low $6.67High $28.00

Volume 0.79M

Average 0.83M

Balance Sheet

Inspect the capital base behind the business.

Assets

$349.78M

FY 2025 · Annual

+335.4% YoY

Liabilities

$17.26M

FY 2025 · Annual

+342.9% YoY

Equity

$332.52M

FY 2025 · Annual

+335.0% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents54.2M22.4M23.49M33.75M88.44M
Short-term Investments113.18M106.82M98.95M44.87M247.72M
Net Receivables00000
Inventory00000
Other Current Assets240K295K250K845K0
Total Current Assets174.33M131.5M124.23M80.12M336.16M
Property, Plant & Equipment (Net)728K1.25M902K215K0
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets302K2.56M2.28M013.62M
Total Non-current Assets1.03M3.8M3.19M215K13.62M
Total Assets175.36M135.3M127.42M80.33M349.78M
Account Payables1.21M2.58M2.4M224K2.15M
Short-term Debt192K385K420K417K0
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities360K3.13M10.45M319K3.32M
Total Current Liabilities2.55M7.78M17.64M3.83M16.54M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities13K71K70K70K0
Total Non-current Liabilities395K776K325K70K724K
Total Liabilities2.95M8.56M17.96M3.9M17.26M
Common Stock2K2K3K3K5K
Retained Earnings(36.39M)(87.9M)(163.42M)(233.05M)(174.39M)
Accumulated OCI(59K)(466K)237K105K129K
Other Stockholders Equity00000
Minority Interest00000
Total Equity172.42M126.74M109.46M76.43M332.52M
Total Debt574K1.09M675K417K724K
Net Debt(53.62M)(21.31M)(22.82M)(33.33M)(87.71M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$55.1M
Short-term Investments$256.2M
Other Current$7.2M
Total Current Assets$318.5M
PP&E (Net)$847.0K
Other Non-current$69.0K
Total Non-current Assets$916.0K
Total Assets$319.4M

Analysis

Selected assets total $319.4M for Latest. The largest visible component is Short-term Investments at $256.2M, about 80.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
10-QQuarterly reportNov 13, 2026
SC 13GSC 13G filingOct 28, 2026
SC 13GSC 13G filingOct 27, 2026
424B5424B5 filingJun 3, 2026

How much cash does JBIO have?

Jade Biosciences, Inc. (JBIO) reported $88.44M in cash and equivalents in fiscal 2025.

How much debt does JBIO carry?

Jade Biosciences, Inc. (JBIO) reported $724,000.00 of total debt, with net debt of -$87.71M.